Caribou Biosciences, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – CRBU

NEW YORK, NY / ACCESSWIRE / January 22, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=124437&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky Before March 10, 2025 to Discuss Your Rights – BIOA

NEW YORK, NY / ACCESSWIRE / January 22, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=124436&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

OG Brands Launches ELEMENT5 Skincare in Hong Kong: Redefining Beauty Across Asia

OG Brands Unveils ELEMENT5: A Pioneering Skincare Line Launch in Hong Kong Marks the Start of an Asian Expansion HONG KONG, HK / ACCESS Newswire / January 22, 2025 / OG Brands by DNO Group is proud to announce the launch of ELEMENT5, the visionary skincare line by renowned aesthetic expert Dr. Mimi Ehrenraich, in

Investors who lost money on MGP Ingredients, Inc. (MGPI) should contact Levi & Korsinsky about pending Class Action – MGPI

NEW YORK, NY / ACCESSWIRE / January 22, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=124438&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Shareholders That Lost Money on Aehr Test Systems, Inc. (AEHR) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / If you suffered a loss on your Aehr Test Systems, Inc. (NASDAQ:AEHR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/aehr-lawsuit-submission-form?prid=124435&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Lost Money on JinkoSolar Holding Co., Ltd. (JKS)? You May Have Been Affected by Fraud – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / January 22, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of JinkoSolar Holding Co., Ltd. ("JinkoSolar Holding Co., Ltd.") (NYSE:JKS) concerning possible violations of federal securities laws. JinkoSolar issued a press release on January 17, 2025, reporting "estimates for certain preliminary unaudited financial

InventHelp Inventor Develops New Aviation Canopy Shade Cover (FMB-289)

“I'm an aviation mechanic and I needed a better canopy shade to protect me against the bright sun and rain when working on a helicopter outside,” said an inventor, from Fresno, Calif., “so I invented the AVIATION CANOPY SHADE COVER. My design eliminates the hassle of setting up a conventional canopy in a work area.”

President and CEO Magnus Groth will leave Essity during 2025

After 14 years with the Group, and almost ten years as president and CEO,Magnus Groth has today informed the Board of Directors of Essity Aktiebolag (publ) that he has decided to step down as CEO and from the Board during 2025. A recruitment process for a successor will be initiated immediately. “As President and CEO

ProactiveMD Expands National Value-Based Network with Strategic Acquisitions in Pathology

ProactiveMD, a leader in value-based, employer-sponsored healthcare, continues to disrupt the industry with aggressive growth, leveraging technology and strategic acquisitions to strengthen its national network. The company recently announced the acquisition of two major pathology groups, one in South Carolina and another in Alabama, marking a significant milestone in its mission to deliver high-quality, cost-effective

Regeneron Pharmaceuticals (REGN) Faces Securities Class Action After Losing $9 Billion Value Following Q3 2024 Earnings Report- Hagens Berman

(NASDAQ:REGN), SAN FRANCISCO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) faces a securities fraud class action after shares of the company plunged $84.59 on Oct. 31, 2024, wiping out about $9 billion of market value. Hagens Berman has opened an investigation into whether Regeneron may have misled investors about its marketing

Scroll to Top